2004-05-07 Biovian provides solutions and services for the biopharmaceutical and diagnostic industry
Did you know that Biovian provides contract manufacturing for biopharmaceutical and diagnostic companies. Biovian is focused on research, development and contract manufacturing of biological molecules such as antibodies and recombinant proteins. Biovians 1 300 m2 GMP facilities and state-of-the-art equipment enables flexible pilot production and development services.
Biovian is a privately-owned, independent company. Biovian is as pure service provider, where the customers project is in focus.
Biovians core business is contract development and manufacturing of therapeutic and diagnostic proteins
We provide full range service from antigen isolation, cell line development, process development, cell cultivation, protein purification to product fill and finish.
Our services include:
Contract research and development services. Typical customer research and development projects include process development, cell line development, assay development and protein characterization
Contract manufacturing of antibodies and other biomolecules for the diagnostic industry. Cost effective cultivation technologies combined with flexible large-scale protein purification systems allow high quality manufacturing of antibodies from milligram-scale up to 100 g per year
GMP contract manufacturing of antibodies and recombinant proteins for preclinical and clinical studies (phases I-II). Biovian has experience in successful development and production of antibodies used in pharmacokinetic and safety studies as well as phase I/II clinical trials
Biovian offers also quality control and other services supporting GMP-related drug manufacturing
Tykistökatu 6B, Biocity
Phone: +358 2 2748840
Fax: +358 2 2748841
16 May 2023
Workshop"AI in clinical diagnostics: challenges and opportunities"| 7 June 2023 17:30-19:00 CET (Hybrid)
10 January 2023
Workshop #3: Reducing Pharmaceutical Residuals in the Baltic Sea Region – Comparative Analysis and Assessment of Possibilities | 9 February at 11:00-15:05 EET
4 January 2023
EDAH - a new European project ahead